Ahead of the Q2 2026 Earnings release
Date: July 30, 2026 (Thursday), Before Market Open
Consensus Estimates: $5.35 billion Revenue (+1.1% yoy); $1.50 EPS (+4.2% yoy)
Guidance: Altria’s FY26 guidance targets an EPS range of $5.56 to $5.72, representing 2.5% to 5.5% growth over 2025
Notes: Following four consecutive years of net revenue declines (FY2022–FY2025), Altria is expected to return to modest top-line growth in 2026. Q2 and Q3 are typically Altria’s strongest quarters in terms of earnings seasonality.
Q2 2026 Results: Executive Summary
Altria delivered a steady second-quarter 2026 performance, demonstrating pricing power in combustibles and continued margin expansion despite ongoing macroeconomic headwinds affecting consumer disposable income. Adjusted Diluted EPS grew 2.8% yoy to $1.48, slightly missing consensus estimate of $1.50. Results were primarily driven by higher adjusted Operating Companies Income (OCI) in the smokeable segment and fewer shares outstanding from ongoing share repurchases.
Management narrowed its full-year 2026 Adjusted EPS guidance from $5.56 – $5.72 to $5.61 – $5.72 (representing 3.5% to 5.5% yoy growth from $5.42 in FY25). Narrowed guidance range reflects a greater benefit from cigarette import and export activity in the second half of the year than in the first half. Additionally, capital expenditure guidance was raised to $375- $450 million to support the USSTC manufacturing facility consolidation (previously, $300 – $375 million).
Key Assumptions: Guidance assumes moderated e-vapor growth, macro uncertainty for adult nicotine consumers, non-continuation of NJOY ACE in the marketplace during 2026, and balanced second-half benefits from import/export cigarette activity.
– Net Revenue (ex-excise): Up +1.2% to $5.26 billion, as higher pricing and import/export volume gains offset volume declines in oral tobacco and combustibles.
– Adj. EPS: Up +2.8% to $1.48. Reported EPS impacted by $88 million pre-tax charges related to the USSTC facility consolidation and $95 million in tobacco/health litigation costs.
Smokeable Products Segment
The smokeable segment continues to serve as Altria’s primary cash engine, maintaining strong pricing power and margin resilience.
– Financial Metrics: Revenues net of excise taxes grew 2.0% to $4,660 million. Adjusted OCI increased 2.4% to $3,018 million, with Adjusted OCI margins expanding by 0.3 percentage points to 64.8%.
– Shipment Volumes: Total cigarette volume declined 3.2% to 15.55 billion sticks. Adjusted for trade inventory, shipment volume dropped 4.5% (total domestic cigarette industry volume: -5%). Marlboro volume fell 7.4% to 13.39 billion sticks, partially offset by a 67.3% surge in Discount volume (1.49 billion sticks) driven by the expansion of Basic.
– Cigar & Export Highlights: Black & Mild cigars grew 5.0% to 503 million units. Contract manufactured export cigarettes surged 54.9% to 736 million sticks.
– Retail Share & Pricing Trends: Marlboro retail pack price increased by $0.60 yoy to $10.15. Marlboro total category retail share decreased 1.5 percentage points yoy to 39.5%. However, Marlboro held a dominant 59.6% share of the premium segment. Total PM USA market share stood at 45.5% (+0.3 pp yoy). Industry discount share grew to 33.8% (+2.6 pp yoy), reflecting macro pressures on adult smokers. Basic’s market share reached 2.9% in Q2 2026 (+2.3pp).
Oral Tobacco Products Segment
Performance in oral tobacco reflected the secular mix shift from traditional Moist Smokeless Tobacco (MST) toward oral nicotine pouches.
Financial Metrics: Net revenue dropped 5.3% yoy to $713 million (Revenues net of excise taxes fell 5.2% to $690 million). Adjusted OCI declined 8.0% to $460 million, with Adjusted OCI margins contracting 2.0 percentage points to 66.7%.
Shipment Volumes: Reported volume fell 8.5% to 181.7 million cans (-2% adjusted for trade inventory). Copenhagen fell 10.9% to 85.4M cans (retail price: $7.78/can), Skoal fell 13.7% to 29.5M cans, and on! pouches fell 4.2% to 49.9M cans (retail price: $4.50/can). Despite year-on-year on! shipment volume decline, total on! consumer off-take is up on a sequential basis.
Nicotine Pouch & Smoke-Free Expansion: Nicotine pouches now represent 59.9% (+8.1 pp yoy) of the oral tobacco category. on! achieved an 8.6% share of total oral tobacco (+0.3 pp yoy, +0.8 pp QoQ) and a 14.4% share of the pouch segment. In Q2 2026, Altria resumed shipments of 12mg on! PLUS in Florida, North Carolina and Texas in Mint, Wintergreen and Tobacco, with a national expansion planned for the third quarter. At the end of July, on! PLUS is available in 120,000 stores nationwide. Altria plans to expand its on! PLUS portfolio with additional flavors across 6mg, 9mg and 12mg nicotine strengths, beginning with Blueberry Mint and Mango Pineapple, in the fourth quarter.
E-vapor Segment
Management offered no update on the return of NJOY ACE to the U.S. market, maintaining its baseline expectation that NJOY ACE will not return during 2026. Meanwhile, overall U.S. e-vapor market growth has moderated as federal and state enforcement efforts against illicit disposables accelerate. The total number of U.S. vapers declined to 20.0 million at the end of June 2026 (down from 20.5 million a year ago). However, the illicit vape user base – primarily consuming unauthorized disposables -remained sticky at 14.6 million users, representing ~73% of the total U.S. vape users.
Balance Sheet & Capital Allocation
Altria returned nearly $3.9 billion to shareholders in the first half of 2026 through dividends and share repurchases.
– Share Repurchases: In Q2 2026, Altria repurchased 0.8 million shares for $55 million (average price $65.11/share). First-half buybacks totaled 5.3 million shares ($335 million). $665 million remains on the current authorization expiring December 31, 2026.
– Dividends: Paid $1.8 billion in dividend distributions during Q2 2026.
– Debt & Liquidity: Ended Q2 2026 with $2.37 billion in cash and cash equivalents and total long-term debt (including current portion) of $24.58 billion (down from $25.71 billion at FY 2025 end). 1.9x debt-to-EBITDA ratio as of June 30, 2026.
Downloads:
Altria – Q2 2026 – Press Release
